期刊文献+

亨廷顿病脑部CT、MRI形态学及磁共振波谱成像研究

Huntington's Disease: evaluation of brain CT, MRI and 1H- MRS images
下载PDF
导出
摘要 目的研究2个亨廷顿病家系亨廷顿病患者的颅脑常规CT、MRI及磁共振波谱成像(^1H—MRspec—troscopy,MRS)表现。方法对2个亨廷顿病家系的6例亨廷顿病患者行头颅常规CT、MRI及MRS检查,并与20例正常志愿者进行比较,检查序列包括:CT平扫、MRIT1WI、T2WI、FLAIR及MRS。结果颅脑CT、MRI显示亨廷顿患者的两侧尾状核、壳核萎缩,两侧侧脑室前角扩大;两侧尾状核头及壳核的NAA/Cr比值降低,Ch/Cr比值升高(P〈0.05)。结论亨廷顿病的CT、MRI主要表现为两侧尾状核、壳核萎缩;尾状核、壳核的^1H—MRS代谢异常有助于亨廷顿病的诊断。 Objective To investigate the brain CT, MRI and MRS images of patients with Huntington's disease from two families. Methods Six patients with Huntington's disease underwent CT, MRI and MRS scanning, including con- ventional CT, T1WI, T2WI, FLAIR and MRS. These data were then compared with those collected from 20 healthy sub- jects. Results According to the brain CT and MRI images, these patients presented atrophy of the bilateral caudate nu- cleus and putamen, as well as the enlargement of anterior horn of the bilateral ventricles. MRS results showed a de- creased ratio of NAA/Cr and an increase in the ratio of Cho/Cr in the bilateral caudate nucleus and putamen (P 〈 0.05). Conclusions The images of brain CT and MRI indicated atrophy of the bilateral caudate nucleus and putamen. Abnormal metabolism on ^1H -MRS could be helpful for the diagnosis of Huntington's disease.
出处 《徐州医学院学报》 CAS 2014年第12期911-914,共4页 Acta Academiae Medicinae Xuzhou
关键词 亨廷顿病 体层摄影术 X线计算机 磁共振成像 Huntington's disease tomography X- ray computed magnetic resonance imaging
  • 相关文献

参考文献9

  • 1亨廷顿病的诊断与治疗指南[J].中华神经科杂志,2011,44(9):638-641. 被引量:20
  • 2Montoya A,Price BH,Menear M,et al. Brain imaging and cogni-tive dysfunctions in Huntington's disease [ J]. J Psychiatry Neu-rosoi, 2006,31(1) :21 -29.
  • 3王秀英,刘福民,叶月仙,潘爱胜,许志大,曾溢涛,毛跃华,陈美珏.亨廷顿氏病发病及基因诊断[J].中国神经精神疾病杂志,1998,24(2):96-98. 被引量:4
  • 4杨春,徐凯,华荣,于春雨,耿德勤,马红,陈高红,荣玉涛,路欣.亨廷顿病的脑部MRI表现[J].中华放射学杂志,2014,48(4):337-339. 被引量:3
  • 5冯一鸣,张东友,汪晶,彭虹芬.亨廷顿病的影像学表现[J].临床放射学杂志,2008,27(10):1426-1428. 被引量:12
  • 6田士强,张宇清,李勇杰.磁共振成像在亨廷顿病诊断中的应用价值[J].中国神经精神疾病杂志,2002,28(6):430-430. 被引量:6
  • 7Mascalchi M, Lolli F, Della Nave R, et al. Huntington disease:volumetric,diffusion - weighted,and magnetization transfer MRimaging of brain [J]. Radiology, 2004,232(3) :867 - 873.
  • 8Sturrock A, Laule C, Decolongon J, et al. Magnetic resonancespectroscopy biomarkers in premanifest and early Huntington dis-ease [J']. Neurology, 2010,75(19) ;1702 -1710.
  • 9Unschuld PG, Edden RA, Carass A, et al. Brain metabolite alter-ations and cognitive dysfunction in early Huntington' s disease[J]. Mov2012,27(7) :895 -902.

二级参考文献45

  • 1张宝荣,殷鑫浈,夏昆,包颖颖,胡正茂,田均,刘志蓉,夏家辉.舞蹈病家系临床、影像学特征及基因突变分析[J].中华神经科杂志,2005,38(11):686-689. 被引量:7
  • 2The Huntington' s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington' s disease chromosomes. Cell, 1993,72 : 971-983.
  • 3Walker FO. Huntington' s disease. Lancet,2007,369 : 218-228.
  • 4Novak MJ, Tabrizi SJ. Huntington's disease. BMJ, 2010, 340: c3109.
  • 5Phillips W, Shannon KM, Barker RA. The current clinical management of Huntington' s disease. Mov Disord, 2008, 23: 1491-1504.
  • 6Harris MK, Shneyder N, Borazanei A, et al. Movement disorders. Med Clin North Am, 2009, 93:371-388, viii.
  • 7Rosenblatt A, Ranen NG, Nance MA, et al. A Physician' s Guide to the Management of Huntington Disease. 2rid ed. New York: Huntington's Disease Society of America, 1999.
  • 8Huntington Study Group. Unified Huntington' s Disease Rating Scale: reliability and consistency. Mov Disord, 1996, 11:136- 142.
  • 9Potter NT, Spector EB, Prior TW. Technical standards and guidelines for Huntington disease testing. Genet Med, 2004, 6: 61-65.
  • 10Bonelli RM, Wenning GK. Pharmacological management of Huntington' s disease: an evidence-based review. Curt Pharm Des, 2006, 12:2701-2720.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部